Decibel Cannabis Company Inc.
Decibel Cannabis Company Inc.
Your view on DBCCF
Overview
What the company does, where it operates, and who runs it.
About Decibel Cannabis Company Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Benjamin Sze
- Headquarters
- 140 - 4th Avenue SW, Calgary, AB, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Benjamin Sze
- Headquarters
- 140 - 4th Avenue SW, Calgary, AB, CA
Decibel Cannabis Company Inc. engages in the cultivation, processing, production, and retail sale of cannabis products in Canada. It offers cannabis flower, cannabis pre-rolls, and cannabis biomass to licensed producers in Canada.
The company is also involved in the extraction, processing, and manufacturing of various cannabis derivative products, including vape cartridges, cannabis infused products, and cannabis extracts. It offers its products under the Qwest, Qwest Reserve, Blendcraft by Qwest, and General Admission brands.
Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Decibel Cannabis Company Inc., and the rating behind it. DBCCF last traded at $0.07; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Decibel Cannabis Company Inc.. Starting points for Decibel Cannabis Company Inc.: EPS -$0.02, beta 0.94 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Decibel Cannabis Company Inc.. Decibel Cannabis Company Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Decibel Cannabis Company Inc.. Trailing twelve-month EPS for Decibel Cannabis Company Inc. stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Decibel Cannabis Company Inc.. Decibel Cannabis Company Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Decibel Cannabis Company Inc. valued side by side against its closest peers. Decibel Cannabis Company Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Decibel Cannabis Company Inc., and how their positions are changing. At a $43.3M market value, institutional positions materially move Decibel Cannabis Company Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Decibel Cannabis Company Inc. executives and directors. Shares of Decibel Cannabis Company Inc. have traded between $0.03 and $0.11 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Decibel Cannabis Company Inc.. Decibel Cannabis Company Inc. is a $43.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Decibel Cannabis Company Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Decibel Cannabis Company Inc.. Coverage tracks Decibel Cannabis Company Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.